Vireo Growth Inc. is a cannabis company that cultivates, manufactures, and distributes medical and adult-use cannabis products across several U.S. states. While it boasts a solid gross margin of 45.5% and an EBITDA margin of 14.2%, concerns arise from its negative net margin and low return metrics, indicating profitability challenges. The current ratio is just above 1, suggesting liquidity is tight, and the debt-to-equity ratio of 0.73 shows moderate leverage. Overall, the company has potential but faces significant financial hurdles that could impact growth.
Loading financial metrics...
Company posted a loss of $-67.1M over the last year, representing 13.1% of revenue.
Debt of $322.4M is 3.1x the company's cash position of $104.1M.
Exceptional revenue growth of 424.1% YoY demonstrates strong market demand and competitive positioning.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Drug Manufacturers - Specialty & Generic companies of a similar size
Based on 2026-Q2 (June 30, 2026)